Explore how digital therapeutics (DTx) are reshaping mental health treatment and transforming patient care. This session will guide you through the intricacies of regulatory approval for DTx, highlight the latest evidence-based options, and provide practical strategies for evaluating their effectiveness in clinical practice. Join us to stay ahead in this rapidly advancing field and enhance your ability to make informed decisions about digital tools for mental health.
Opening remarks for AAPP 2025 will be streamed before this session.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Faculty Information
View biographical information
Timothy Aungst, PharmD
Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences
Worcester, MA
Timothy Aungst, PharmD, is a professor of pharmacy practice and clinical pharmacist. He is clinically trained in ambulatory care, with a focus on cardiology and cardiometabolic conditions, alongside geriatric care. For the past decade, Timothy has focused upon the role of technology within clinical care. This has included the evaluation of mobile medical applications and constructing frameworks to identify clinically relevant mobile health tools. This has included evaluating over 2000+ mobile apps and related digital health products and serving as a mentor and judge for the MIT hacking medicine program. By combining his clinical knowledge with his digital health knowledge, he has become a leading subject matter expert on integrating smart medications, digital therapeutics, digital medicines, and remote patient monitoring, and digitalizing patient care. He has served in multiple digital health adivisorial roles related to clinical decision-making and payor coverage. He is a current advisor for the digital therapeutics alliance and aids the digital medicine society. Lastly, bridging his experience as an educator, he is leading committees within the American Pharmacist Association and the American Association of Colleges of Pharmacy to create standards of digital health care for current and future learners and the creation of certificates and training modules to get the pharmacy profession ready for the era of digital health care.
Learning Objectives
- Explain the difference between health and wellness applications and digital therapeutics (DTx)
- Describe DTx and its place in the treatment of mental health.
- Explain the regulatory process involved in clearing DTx applications through the FDA and other regulatory bodies.
- Identify if an available DTx application is evidence-based and recommended for use in the treatment of various mental illnesses.
Continuing Education Credit and Disclosures
Activity Dates: 04/27/2025 - 04/27/2028
ACPE Contact Hours: 1
ACPE Number: 0284-0000-25-002-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.